Introducing the RenMice Series 2: Biocytogen’s Latest Breakthrough in Biotechnology
Fully Human Antibody and TCR Mouse Models Showcase Biocytogen’s Capabilities to Innovate the Discovery of Novel Biologic Drugs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) officially announces the RenMice® series, which includes a collection of independently developed, fully human antibody mice and TCR mice with proprietary intellectual property. The term “Ren”, defined as […]….